Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 537 du 19 septembre 2022
Qualité de vie, soins de support (1)
Menée en Norvège à partir de données portant sur 730 patients atteints d'un cancer du poumon non à petites cellules de stade avancé, cette étude analyse l'évolution de leurs symptômes et de leur qualité de vie durant leur dernière année de vie
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer
Menée en Norvège à partir de données portant sur 730 patients atteints d'un cancer du poumon non à petites cellules de stade avancé, cette étude analyse l'évolution de leurs symptômes et de leur qualité de vie durant leur dernière année de vie
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer
Kristensen, Are ; Grønberg, Bjørn Henning ; Fløtten, Øystein ; Kaasa, Stein ; Solheim, Tora Skeidsvoll
Background : The aims of this study were to assess the trajectory of health-related quality of life (HRQOL) during the last year of life in patients with advanced non-small–cell lung cancer (NSCLC) and to explore when and to what degree deterioration of symptoms and physical functioning accelerate towards the end of life. Methods : Data from two RCTs of first-line chemotherapy in advanced NSCLC was analyzed. HRQOL was assessed repeatedly using the EORTC QLQ-C30 and LC13. Changes in HRQOL scores [...]
Observation (7)
Menée aux Etats-Unis à partir de données portant sur 8 962 patients atteints d'un cholangiocarcinome intrahépatique diagnostiqué entre 2000 et 2018, cette étude analyse la survie et les causes de décès (7 335 décès dont 4 832 décès par cholangiocarcinome)
Survival and Causes of Death among Patients with Intrahepatic cholangiocarcinoma in the United State from 2000 to 2018
Menée aux Etats-Unis à partir de données portant sur 8 962 patients atteints d'un cholangiocarcinome intrahépatique diagnostiqué entre 2000 et 2018, cette étude analyse la survie et les causes de décès (7 335 décès dont 4 832 décès par cholangiocarcinome)
Survival and Causes of Death among Patients with Intrahepatic cholangiocarcinoma in the United State from 2000 to 2018
Elgenidy, Anas ; Afifi, Ahmed M. ; Jalal, Prasun K.
Background: Intrahepatic cholangiocarcinoma (ICCA) has shown a substantial increase in mortality globally. On the contrary, perihilar cholangiocarcinoma and distal cholangiocarcinoma have been decreasing. We aim to evaluate the causes of death after ICCA diagnosis. Methods: We studied 8,962 ICCA patients diagnosed between 2000 and 2018 in the United States. The standardized mortality ratio (SMR) for each cause of death was calculated. We used R software version 3.5 to perform Kaplan-Meier [...]
A partir d'une revue systématique de la littérature publiée jusqu'en février 2022 (22 interventions), cette étude analyse l'utilisation d'entretiens motivationnels pour améliorer les comportements de santé (activité physique, nutrition)
Motivational interviewing interventions aiming to improve health behaviors among cancer survivors: a systematic scoping review
A partir d'une revue systématique de la littérature publiée jusqu'en février 2022 (22 interventions), cette étude analyse l'utilisation d'entretiens motivationnels pour améliorer les comportements de santé (activité physique, nutrition)
Motivational interviewing interventions aiming to improve health behaviors among cancer survivors: a systematic scoping review
Seven, Memnun ; Reid, Allecia ; Abban, Sabriye ; Madziar, Camilla ; Faro, Jamie M.
Purpose : The scoping review aimed to map out the literature on the utilization of motivational interviewing (MI) to improve health behaviors (i.e., physical activity, nutrition) in adult cancer survivors. Methods : This scoping review was conducted following the methods and protocol outlined by the Joanna Briggs Institute Methods Manual. Five databases, including PubMed, CINAHL, Web of Science, and SPORTDiscus, were searched in February 2022 to identify MI interventions to improve health [...]
Menée au Canada à partir de données portant sur 535 patients atteints d'un cancer du poumon non à petites cellules de stade précoce ayant été réséqué, cette étude de cohorte rétrospective analyse la présence de mutations du gène EGFR, les traitements reçus, le taux de récidive et la survie
EGFR Mutation Prevalence, Real-world Treatment Patterns, and Outcomes among Patients with Resected, Early-stage, Non-small Cell Lung Cancer in Canada
Menée au Canada à partir de données portant sur 535 patients atteints d'un cancer du poumon non à petites cellules de stade précoce ayant été réséqué, cette étude de cohorte rétrospective analyse la présence de mutations du gène EGFR, les traitements reçus, le taux de récidive et la survie
EGFR Mutation Prevalence, Real-world Treatment Patterns, and Outcomes among Patients with Resected, Early-stage, Non-small Cell Lung Cancer in Canada
Sara Kuruvilla, M. ; Liu, Geoffrey ; Syed, Iqra ; Gwadry-Sridhar, Femida ; Sheffield, Brandon S. ; Rakibuz-Zaman, Muhammad ; Liu, Linda ; Sachdeva, Robin ; Pencz, Alec ; Zhan, Luna ; Hueniken, Katrina ; Patel, Devalben ; Balaratnam, Karmugi ; Khan, Khaleeq ; Grant, Benjamin ; Noy, Shawna ; Singh, Karan ; Moldaver, Daniel ; Kate Shanahan, Mary ; Cheema, Parneet K.
Objectives : The ADAURA trial demonstrated the benefit of adjuvant osimertinib among patients with resected, early-stage, epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). To understand the potential population impact, it is critical to deduce the prevalence, management, and outcomes of this patient population in the real-world setting before use of adjuvant osimertinib. Materials and Methods : Using PALEOS (Pan-cAnadian Lung cancEr Observational Study) data [...]
Menée en Suède à partir de données portant sur 23 655 patients atteints d'un cancer de la prostate et sous surveillance active (âge médian au diagnostic : 69 ans), cette étude de cohorte présente une estimation des décès par cancer et par autre cause
Exploring the Long-term Outcomes of Active Surveillance Among Men With Prostate Cancer—Best for Whom?
Menée en Suède à partir de données portant sur 23 655 patients atteints d'un cancer de la prostate et sous surveillance active (âge médian au diagnostic : 69 ans), cette étude de cohorte présente une estimation des décès par cancer et par autre cause
Exploring the Long-term Outcomes of Active Surveillance Among Men With Prostate Cancer—Best for Whom?
Elmehrath, Ahmed O.
In an effort to investigate the long-term outcomes of active surveillance (AS) among men with prostate cancer (PC), Ventimiglia et al1 developed a simulation model with a 30-year follow-up trajectory for men with PC managed with AS. The data used to develop the model were retrieved from the Prostate Cancer data Base Sweden (PCBaSe) and covered a follow-up period from 1992 to 2014. Men aged 40 to 75 years at diagnosis of very low-risk, low-risk, or intermediate-risk PC according to modified [...]
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
Menée en Suède à partir de données portant sur 23 655 patients atteints d'un cancer de la prostate et sous surveillance active (âge médian au diagnostic : 69 ans), cette étude de cohorte présente une estimation des décès par cancer et par autre cause
Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
Ventimiglia, Eugenio ; Bill-Axelson, Anna ; Bratt, Ola ; Montorsi, Francesco ; Stattin, Pär ; Garmo, Hans
Importance : The long-term outcomes among men with prostate cancer (PC) whose disease is managed with active surveillance (AS) remains unknown. Objective : To develop a simulation model with a 30-year follow-up for men with PC managed with AS. Design, Setting, and Participants : In this cohort study, a state transition model was created using data from Prostate Cancer data Base Sweden (PCBaSe) on 23 655 men diagnosed with PC and managed with deferred treatment to estimate treatment [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis
Alhumaid, Saad ; Al Mutair, Abbas ; Busubaih, Jawad S. ; Al Dossary, Nourah ; Alsuliman, Murtadha ; Baltyour, Sarah A. ; Alissa, Ibrahim ; Al Hassar, Hassan I. ; Al Aithan, Noor A. ; Albassri, Hani A. ; AlOmran, Suliman A. ; Alghazal, Raed M. ; Busbaih, Ahmed ; Alsalem, Nasser A. ; Alagnam, Waseem ; Alyousef, Mohammed Y. ; Alseffay, Abdulaziz U. ; Al Aish, Hussain A. ; Aldiaram, Ali ; Al eissa, Hisham A. ; Alhumaid, Murtadha A. ; Bukhamseen, Ali N. ; Al mutared, Koblan M. ; Aljwisim, Abdullah H. ; Twibah, Abdullah M. ; AlSaeed, Meteab M. ; Alkhalaf, Hussien A. ; Alshakhs, Fatemah M. ; Koritala, Thoyaja ; Al-Tawfiq, Jaffar A. ; Dhama, Kuldeep ; Rabaan, Ali A. ; Al-Omari, Awad
Background: Patients with colorectal cancer (CRC) are more likely to develop severe course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and experience increased risk of mortality compared to SARS-CoV-2 patients without CRC. Objectives: To estimate the prevalence of SARS-CoV-2 infection in CRC patients and analyse the demographic parameters, clinical characteristics and treatment outcomes in CRC patients with COVID-19 illness. Methods: For this systematic review and [...]
SARS-CoV-2 infection in patients treated with azacitidine and venetoclax for acute leukemia – a report of a case series treated in a single institu...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
SARS-CoV-2 infection in patients treated with azacitidine and venetoclax for acute leukemia – a report of a case series treated in a single institution
Drozd-Sokolowska, J. ; Mądry, K. ; Barankiewicz, J. ; Kobylińska, K. ; Biecek, P. ; Rytel, J. ; Karakulska-Prystupiuk, E. ; Skwierawska, K. ; Salomon-Perzyński, A. ; Stokłosa, T. ; Basak, G. W.
Introduction : Venetoclax combined with azacitidine (AZA-VEN) constitutes an option for the treatment of acute myeloid leukemia. There is however no data on the COVID-19 incidence and outcome in patients treated with AZA-VEN. Methods : Patients with acute leukemia (AL) treated with AZA-VEN at single institution were included in this prospective observational study. Results : Thirteen patients were enrolled, 46% with treatment-naïve, and 56% with relapsed/refractory disease. Fifty-four percent [...]
Effects of COVID-19 on Surgical Delays in Patients with Breast Cancer in NYC Public Hospitals: A Multicenter Study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Effects of COVID-19 on Surgical Delays in Patients with Breast Cancer in NYC Public Hospitals: A Multicenter Study
Escobar, Natalie ; DiMaggio, Charles ; Pocock, Benjamin ; Pescovitz, Allison ; McCalla, Sydney ; Joseph, Kathie-Ann
Background : Increased time to surgery (TTS) is associated with decreased survival in patients with breast cancer. In early 2020, elective surgeries were canceled to preserve resources for patients with coronavirus disease 2019 (COVID-19). This study attempts to measure the effect of mandated operating room shutdowns on TTS in patients with breast cancer. Patients and Methods : This multicenter retrospective study compares 51 patients diagnosed with breast cancer at four public hospitals from [...]
Outcomes of lung cancer surgery in patients with COVID-19 history: a single center cohort study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Outcomes of lung cancer surgery in patients with COVID-19 history: a single center cohort study
Gabryel, Piotr ; Zielińska, Dominika ; Skrzypczak, Piotr ; Sielewicz, Magdalena ; Campisi, Alessio ; Kasprzyk, Mariusz ; Piwkowski, Cezary
Objectives : Coronavirus disease 2019 (COVID-19) can irreversibly damage the lungs and could possibly increase the risk of surgical treatment of lung cancer. The study aimed to assess the relationship between preoperative COVID-19 and complications and early outcomes of lung cancer surgery. Methods : This single-center cohort study included 444 patients who underwent lobectomy or segmentectomy for primary lung cancer from January 1, 2019 to December 31, 2021. The exclusion criteria were [...]
Risk Factors for Severe Infection and Mortality in COVID-19 and Monoclonal Gammopathy of Undetermined Significance
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Risk Factors for Severe Infection and Mortality in COVID-19 and Monoclonal Gammopathy of Undetermined Significance
Ho, Matthew ; Zanwar, Saurabh ; Buadi, Francis K ; Ailawadhi, Sikander ; Larsen, Jeremy T ; Bergsagel, P Leif ; Binder, Moritz ; Chanan-Khan, Asher A ; Dingli, David ; Dispenzieri, Angela ; Fonseca, Rafael ; Gertz, Morie A ; Gonsalves, Wilson I ; Go, Ronald S. ; Hayman, Suzanne R ; Kapoor, Prashant ; Kourelis, Taxiarchis V. ; Lacy, Martha Q ; Leung, Nelson ; Lin, Yi ; Muchtar, Eli ; Roy, Vivek ; Sher, Taimur ; Warsame, Rahma ; Fonder, Amie L ; Hobbs, Miriam A ; Hwa, Yi Lisa ; Kyle, Robert A ; Rajkumar, S. Vincent ; Kumar, Shaji K
Vaccines have been 32 instrumental in reducing incidence and severity of COVID-19 with efficacy rate of about 95% reported in phase 3 clinical data for both the mRNA vaccines (Pfizer and Moderna). These studies excluded immunocompromised patients, including those with hematologic malignancies. Patients with multiple myeloma (MM) have inferior vaccine efficacy and COVID-19 infections are more severe, especially in patients being treated with anti-CD38 or anti-B-cell maturation antigen (BCMA) [...]
Clonal Hematopoiesis of Indeterminate Potential and Risk of Death from COVID-19
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Clonal Hematopoiesis of Indeterminate Potential and Risk of Death from COVID-19
Miller, Peter ; Fell, Geoffrey ; Foy, Brody ; Scherer, Allison ; Gibson, Christopher J. ; Sperling, Adam S. ; Burugula, Bala Bharathi ; Nakao, Tetsushi ; Uddin, Md Mesbah ; Warren, Hailey ; Bry, Lynn ; Pozdnyakova, Olga ; Frigault, Matthew J ; Bick, Alexander G. ; Neuberg, Donna ; Higgins, John M ; Mansour, Michael ; Natarajan, Pradeep ; Kim, Annette S. ; Kitzman, Jacob ; Ebert, Benjamin L.
Clonal hematopoiesis is an age-related phenomenon in which a clonal population of blood cells emerges and is often detected by the presence of a mutation present in a peripheral blood sample. Clonal hematopoiesis of indeterminate potential (CHIP) is a subtype of clonal hematopoiesis found in individuals without a hematologic malignancy in which a somatic pathogenic mutation in a gene mutated in myeloid neoplasia is present in at least 2% of the sequenced blood DNA (termed variant allele [...]
Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19
D. Peixoto ; K.Y. Ibrahim
We sought to compare the clinical presentation and prognosis of patients with lung cancer and confirmed COVID-19 infection to those with negative RT-PCR SARS-CoV-2 results. We included patients with confirmed lung cancer and suspected COVID-19 who presented to the emergency department. The primary outcome was in-hospital mortality and secondary outcomes included admission to intensive care unit (ICU) or mechanical ventilation. We analyzed the characteristics according to RT-PCR results and [...]
Menée aux Etats-Unis à partir de données portant sur 666 patients atteints d'un cancer du rectum (255 femmes et 411 hommes), cette étude rétrospective analyse l'effet de l'âge sur le choix des traitements, la survenue de complications post-opératoires et la survie
The impact of age on rectal cancer treatment, complications and survival
Menée aux Etats-Unis à partir de données portant sur 666 patients atteints d'un cancer du rectum (255 femmes et 411 hommes), cette étude rétrospective analyse l'effet de l'âge sur le choix des traitements, la survenue de complications post-opératoires et la survie
The impact of age on rectal cancer treatment, complications and survival
Høydahl, Øystein ; Edna, Tom-Harald ; Xanthoulis, Athanasios ; Lydersen, Stian ; Endreseth, Birger Henning
Background : The number of older patients with rectal cancer is increasing. Treatment outcome discrepancies persist, despite similar treatment guidelines. To offer the oldest patients optimal individually adjusted care, further knowledge is needed regarding treatment strategy and outcome. The present study aimed to evaluate treatment, postoperative complications, and survival in older patients treated for rectal cancer. Methods : This retrospective study included all 666 patients (n=255 [...]
Menée dans l'Etat de Californie sur la période 1988-2019, cette étude analyse l'association entre des facteurs sociodémographiques et la survie chez des patients atteints d'un cancer de l'ouraque
Association of Sociodemographic Characteristics With Survival Among Patients With Urachal Cancer in California From 1988 to 2019
Menée dans l'Etat de Californie sur la période 1988-2019, cette étude analyse l'association entre des facteurs sociodémographiques et la survie chez des patients atteints d'un cancer de l'ouraque
Association of Sociodemographic Characteristics With Survival Among Patients With Urachal Cancer in California From 1988 to 2019
Benjamin, David J. ; Shrestha, Anshu ; Fellman, Dimitra ; Cress, Rosemary D. ; Kalebasty, Arash Rezazadeh
Urachal cancer is a rare genitourinary malignant neoplasm that arises from the remnant of the embryological structure between the bladder and allantois. It has been considered an extremely aggressive neoplasm, with a median overall survival (OS) ranging between 12 and 24 months among patients with locally advanced and metastatic disease. Surgery is the preferred treatment for localized and regional disease, and chemotherapy and/or immunotherapy are recommended for metastatic disease. We [...]
Approches psycho-sociales (6)
Menée aux Pays-Bas par questionnaire auprès de 150 parents et proches de patients décédés d'un cancer de stade avancé, cette étude prospective longitudinale analyse les facteurs associés à leur état émotionnel pendant le deuil
Emotional functioning during bereavement after the death of patients with advanced cancer and associated factors
Menée aux Pays-Bas par questionnaire auprès de 150 parents et proches de patients décédés d'un cancer de stade avancé, cette étude prospective longitudinale analyse les facteurs associés à leur état émotionnel pendant le deuil
Emotional functioning during bereavement after the death of patients with advanced cancer and associated factors
Ham, Laurien ; Fransen, Heidi P ; van Roij, Janneke ; van den Borne, Ben ; Creemers, Geert Jan ; Hendriks, Mathijs P ; Kuip, Evelien ; van Laarhoven, Hanneke WM ; van Leeuwen, Lobke ; van der Padt – Pruijsten, Annemieke ; Smilde, Tineke ; Stellingwerf, Margriet ; van Zuylen, Lia ; van de Poll – Franse, Lonneke ; Raijmakers, Natasja JH
Objective : The death of a loved one is considered to be the most stressful of all life events. However, the impact of bereavement on quality of life varies between individuals. The aim of our study was to assess emotional functioning, which is a domain of quality of life, of bereaved relatives after the death of their loved one and its associated factors. Method : A prospective, longitudinal, multicenter, observational study on quality of care and quality of life of patients with advanced [...]
Menée aux Etats-Unis à partir de données portant sur 2 049 patients atteints d'un cancer (âge moyen : 68,1 ans), cette étude analyse l'association entre leur situation professionnelle, des difficultés financières, l'adhésion aux traitements et des symptômes de dépression et d'anxiété
Financial Worry in People with Cancer: Relationship to Employment and Outcomes
Menée aux Etats-Unis à partir de données portant sur 2 049 patients atteints d'un cancer (âge moyen : 68,1 ans), cette étude analyse l'association entre leur situation professionnelle, des difficultés financières, l'adhésion aux traitements et des symptômes de dépression et d'anxiété
Financial Worry in People with Cancer: Relationship to Employment and Outcomes
Jones, Salene M. W.
Background : People with cancer experience financial hardship. Most previous research has focused on material financial burden rather than financial worry. This study investigated employment predictors of financial worry and examined outcomes potentially affected by financial worry. Methods : Data from the 2018 National Health Interview Study was used and limited to people diagnosed with cancer and having complete data on relevant variables (n=2049). Preliminary analyses indicated three [...]
Menée en Chine à partir de données portant sur 2 930 patient atteints d'un cancer de stade avancé ne présentant pas de symptômes majeurs de dépression, cette étude analyse les facteurs associés à des idées suicidaires
Suicidal Ideation in Advanced Cancer Patients without Major Depressive Disorder
Menée en Chine à partir de données portant sur 2 930 patient atteints d'un cancer de stade avancé ne présentant pas de symptômes majeurs de dépression, cette étude analyse les facteurs associés à des idées suicidaires
Suicidal Ideation in Advanced Cancer Patients without Major Depressive Disorder
Tang, Lili ; He, Yi ; Pang, Ying ; Su, Zhongge ; Zhou, Yuhe ; Wang, Yu ; Lu, Yongkui ; Jiang, Yu ; Han, Xinkun ; Song, Lihua ; Wang, Liping ; Li, Zimeng ; Lv, Xiaojun ; Wang, Yan ; Yao, Juntao ; Liu, Xiaohong ; Zhou, Xiaoyi ; He, Shuangzhi ; Zhang, Yening ; Song, Lili ; Li, Jinjiang ; Wang, Bingmei
Introduction : Major depressive disorder (MDD) is associated with an increased risk of suicide and suicide attempt among cancer patients. However, we do not know how many cancer patients without MDD have suicidal ideation (SI). Objectives : This study aimed to investigate the prevalence, characteristics and correlated factors of SI among advanced cancer patients without MDD. Methods : This is a multi-center, cross-sectional study based on an electronic patient-reported outcome (ePRO) systems in [...]
Menée à partir de données portant sur 1 772 patients atteints d'un cancer de la prostate traité par prostatectomie radicale, cette étude identifie les facteurs associés à leur perception d'eux-mêmes
Cancer-related self-perception in men affected by prostate cancer after radical prostatectomy
Menée à partir de données portant sur 1 772 patients atteints d'un cancer de la prostate traité par prostatectomie radicale, cette étude identifie les facteurs associés à leur perception d'eux-mêmes
Cancer-related self-perception in men affected by prostate cancer after radical prostatectomy
Jahnen, Matthias ; Lehner, Luisa ; Meissner, Valentin H. ; Andreas Dinkel, ; Schiele, Stefan ; Schulwitz, Helga ; Gschwend, Jurgen E. ; Herkommer, Kathleen
Purpose : To identify factors associated with cancer-related self-perception after being affected by prostate cancer (PCa) and radical prostatectomy. Subjects and methods : Men affected by PCa and radical prostatectomy were asked to choose one of 5 cancer-related identities (“patient,” “victim,” “someone who has had cancer,” “cancer survivor,” and “cancer conqueror”). Associations with clinical data, functional outcome (continence and sexual activity), and psychological factors were assessed. [...]
Menée aux Etats-Unis à partir de données portant sur 360 patientes ménopausées atteintes d'un cancer du sein de stade précoce, cette étude de cohorte analyse l'évolution de leurs symptômes neuropsychologiques en lien avec une utilisation d'anastrozole
Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer
Menée aux Etats-Unis à partir de données portant sur 360 patientes ménopausées atteintes d'un cancer du sein de stade précoce, cette étude de cohorte analyse l'évolution de leurs symptômes neuropsychologiques en lien avec une utilisation d'anastrozole
Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer
McCall, Maura K. ; Sereika, Susan M. ; Snader, Stephanie ; Lavanchy, Alexa ; Rosenzweig, Margaret Q. ; Conley, Yvette P. ; Beumer, Jan H. ; Bender, Catherine M.
Purpose : Aromatase inhibitors (AIs) prolong survival for postmenopausal women with hormone receptor-positive breast cancer (HR + BC) but also burden patients with symptoms, a major reason for suboptimal AI adherence. This study characterizes inter-relationships among symptom measures; describes neuropsychological symptom burden trajectories; and identifies trajectory group membership predictors for postmenopausal women prescribed anastrozole for HR + BC. Methods : This study utilized [...]
Menée en Australie par enquête auprès de 116 patients atteints d'un gliome de haut grade, cette étude de cohorte prospective analyse l'évolution de l'intensité de leur détresse psychologique, avant la chimioradiothérapie et 3 et 6 mois après, puis évalue leurs besoins en soins de support
Brain cancer patients’ levels of distress and supportive care needs over time
Menée en Australie par enquête auprès de 116 patients atteints d'un gliome de haut grade, cette étude de cohorte prospective analyse l'évolution de l'intensité de leur détresse psychologique, avant la chimioradiothérapie et 3 et 6 mois après, puis évalue leurs besoins en soins de support
Brain cancer patients’ levels of distress and supportive care needs over time
Halkett, Georgia ; Lobb, Elizabeth ; Spilsbury, Katrina ; Dhillon, Haryana ; Nowak, Anna
Purpose : This study aimed to describe patient self-reported distress over time and how this was associated with wellbeing, and supportive care needs over a six-month period from commencing chemoradiotherapy for high grade glioma (HGG). Methods : In this prospective cohort study, participants completed surveys at three time points: before chemoradiotherapy, at three and six months. These included Distress Thermometer, Functional Assessment of Cancer/Brain Cancer Treatment-general [...]
Analyses économiques et systèmes de soins (1)
Menée dans un contexte américain à partir de données portant sur un total de 199 344 patients atteints d'un cancer (105 255 cas de cancer du sein, 23 571 cas de cancer colorectal, 11 321 cas de cancer du poumon et 59 197 cas de cancer de la prostate), cette étude de cohorte présente une estimation des coûts restant à la charge des patients bénéficiant d'une assurance santé privée, pendant la première année suivant le diagnostic de la maladie
Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured
Menée dans un contexte américain à partir de données portant sur un total de 199 344 patients atteints d'un cancer (105 255 cas de cancer du sein, 23 571 cas de cancer colorectal, 11 321 cas de cancer du poumon et 59 197 cas de cancer de la prostate), cette étude de cohorte présente une estimation des coûts restant à la charge des patients bénéficiant d'une assurance santé privée, pendant la première année suivant le diagnostic de la maladie
Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured
Shih, Ya-Chen Tina ; Xu, Ying ; Bradley, Cathy ; Giordano, Sharon H ; Yao, James ; Yabroff, K Robin
Background : We estimated trends in total and out-of-pocket (OOP) costs around the first year of diagnosis for privately insured nonelderly adult cancer patients. Methods : We constructed incident cohorts of breast, colorectal, lung, and prostate cancer patients diagnosed between 2009 and 2016 using claims data from the Health Care Cost Institute. We identified cancer-related surgery, intravenous (IV) systemic therapy, and radiation and calculated associated total and OOP costs (in 2020 US [...]